Literature DB >> 22231787

Prognostic implication of lymphatic vessel invasion in stage IB (pT2aN0M0) non-small cell lung cancer.

Kunio Araki1, Yoshin Adachi, Hiroyuki Metsugi, Takeshi Tokushima.   

Abstract

PURPOSE: To clarify the prognostic factors for recently revised stage IB non-small cell lung cancer.
METHODS: Twenty-six specimens of completely resected stage IB (pT2aN0M0) non-small cell lung cancer were studied. Clinicopathological profiles of the 26 patients, including age, sex, smoking status, tumor size, histology, pleural invasion, and lymphatic and blood vessel invasion, were assessed. Correlation between tumor recurrence and these factors was assessed by statistical analysis.
RESULTS: Lymphatic vessel invasion was the only statistically significant factor for postoperative tumor recurrence as assessed by multivariate analysis. Kaplan-Meier survival curves showed a 5-year recurrence-free rate of 77.8% in 26 patients with no lymphatic vessel invasion compared with 28.6% in those with lymphatic vessel invasion.
CONCLUSION: Lymphatic vessel invasion of cancer cells was indicated as an independent prognostic factor in revised stage IB non-small cell lung cancer.

Entities:  

Mesh:

Year:  2011        PMID: 22231787     DOI: 10.1007/s11748-011-0782-4

Source DB:  PubMed          Journal:  Gen Thorac Cardiovasc Surg        ISSN: 1863-6705


  9 in total

1.  Stage IA non-small cell lung cancer: vessel invasion is a poor prognostic factor and a new target of adjuvant chemotherapy.

Authors:  Tomoshi Tsuchiya; Shinji Akamine; Masashi Muraoka; Ryotaro Kamohara; Koichi Tsuji; Shogo Urabe; Sumihisa Honda; Naoya Yamasaki
Journal:  Lung Cancer       Date:  2007-03-09       Impact factor: 5.705

2.  Prognostic significance of intratumoral blood vessel invasion in pathologic stage IA non-small cell lung cancer.

Authors:  Fumihiro Shoji; Akira Haro; Tsukihisa Yoshida; Kensaku Ito; Yosuke Morodomi; Tokujiro Yano; Yoshihiko Maehara
Journal:  Ann Thorac Surg       Date:  2010-03       Impact factor: 4.330

3.  Lymphatic vessel density in pulmonary adenocarcinoma immunohistochemically evaluated with anti-podoplanin or anti-D2-40 antibody is correlated with lymphatic invasion or lymph node metastases.

Authors:  Yoshin Adachi; Hiroshige Nakamura; Yukisato Kitamura; Yuji Taniguchi; Kunio Araki; Kohei Shomori; Yasushi Horie; Youichi Kurozawa; Hisao Ito; Kazuhiko Hayashi
Journal:  Pathol Int       Date:  2007-04       Impact factor: 2.534

4.  Clinicopathologic features in resected subcentimeter lung cancer--status of lymph node metastases.

Authors:  Qianjun Zhou; Kenji Suzuki; Yo-ichi Anami; Shiaki Oh; Kazuya Takamochi
Journal:  Interact Cardiovasc Thorac Surg       Date:  2009-10-15

5.  Clinical significance of microvessel count in patients with metastatic liver cancer originating from colorectal carcinoma.

Authors:  Atsushi Nanashima; Kenichirou Shibata; Toshiyuki Nakayama; Syuuichi Tobinaga; Masato Araki; Masaki Kunizaki; Hiroaki Takeshita; Shigekazu Hidaka; Terumitsu Sawai; Takeshi Nagayasu; Toru Yasutake
Journal:  Ann Surg Oncol       Date:  2009-06-04       Impact factor: 5.344

6.  Accuracy and prognostic impact of a vessel invasion grading system for stage IA non-small cell lung cancer.

Authors:  Satoshi Hashizume; Takeshi Nagayasu; Tomayoshi Hayashi; Shigekazu Hidaka; Tomoshi Tsuchiya; Tsutomu Tagawa; Naoya Yamasaki; Katsuro Furukawa; Keitaro Matsumoto; Takuro Miyazaki
Journal:  Lung Cancer       Date:  2009-01-21       Impact factor: 5.705

7.  The clinical significance of lymphangiogenesis and angiogenesis in non-small cell lung cancer patients.

Authors:  Kyuichi Kadota; Cheng-Long Huang; Dage Liu; Masaki Ueno; Yoshio Kushida; Reiji Haba; Hiroyasu Yokomise
Journal:  Eur J Cancer       Date:  2008-04-08       Impact factor: 9.162

8.  Risk of recurrence in patients with surgically resected stage I non-small cell lung carcinoma: histopathologic and immunohistochemical analysis.

Authors:  Claudia Poleri; José Luis Morero; Beatriz Nieva; María Fernanda Vázquez; Cristina Rodríguez; Ernesto de Titto; Moisés Rosenberg
Journal:  Chest       Date:  2003-06       Impact factor: 9.410

9.  The IASLC Lung Cancer Staging Project: proposals for the revision of the T descriptors in the forthcoming (seventh) edition of the TNM classification for lung cancer.

Authors:  Ramón Rami-Porta; David Ball; John Crowley; Dorothy J Giroux; James Jett; William D Travis; Masahiro Tsuboi; Eric Vallières; Peter Goldstraw
Journal:  J Thorac Oncol       Date:  2007-07       Impact factor: 15.609

  9 in total
  2 in total

1.  Lymphatic vessel invasion in pathologic stage I and II non-small cell lung tumors.

Authors:  Hyun Woo Jeon; Kyung Soo Kim; Young-Du Kim; Keon Hyun Jo; Hyung Joo Park; Young Pil Wang; Jae Kil Park
Journal:  Surg Today       Date:  2014-11-26       Impact factor: 2.549

2.  Clinical significance and role of lymphatic vessel invasion as a major prognostic implication in non-small cell lung cancer: a meta-analysis.

Authors:  Jun Wang; Baocheng Wang; Weipeng Zhao; Yan Guo; Hong Chen; Huili Chu; Xiuju Liang; Jingwang Bi
Journal:  PLoS One       Date:  2012-12-20       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.